FDA Inspection 1147262 — OneBlood, Inc.

OneBlood, Inc. — FEI 1072542

The FDA completed an inspection of OneBlood, Inc. on July 20, 2021 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 20, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Tallahassee, FL (United States)

Citations

IDCFRDescription
442521 CFR 606.60(a)Equipment observed, standardized, calibrated